ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease
1. Age ≥18 years at the time of signing informed consent, and at least the legal age of consent in countries where it is \>18 years
2. Signed and dated written informed consent in accordance with international council for harmonisation - good clinical practice (ICH-GCP) and local legislation prior to admission to the trial
3. Body mass index (BMI) ≥27 kg/m²
You may not be if
1. Medications for obesity within 3 months before screening
2. Known or suspected hypersensitivity to the investigational medicinal product (IMP) or related products
3. Established diagnosis of heart failure or a known history of heart failure
